Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierantonio Menna

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 17, 2012
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. I. Amrubicin accumulates to a lower level than doxorubicin or epirubicinEmanuela Salvatorelli, Pierantonio Menna, Sekhar Surapaneni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2012
Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosisEmanuela Salvatorelli, Michele De Tursi, Pierantonio Menna, et al.
Molecules (Basel, Switzerland)|February 24, 2024
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography-Tandem Mass SpectrometryLinda Molteni, Bruno Charlier, Albino Coglianese, et al.
Chemotherapy|November 21, 2018
Isavuconazole: Case Report and Pharmacokinetic ConsiderationsFrancesco Marchesi, Corrado Girmenia, Bianca Maria Goffredo, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2018
The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by AnthracyclinesPierantonio Menna, Emanuela Salvatorelli, Grazia Armento, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2019
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b MinitrialGiorgio Minotti, Pierantonio Menna, Vito Calabrese, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2018
Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline ChemotherapyPierantonio Menna, Vito Calabrese, Grazia Armento, et al.
The Journal of Biological Chemistry|November 25, 2003
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobinAntonella Cartoni, Pierantonio Menna, Emanuela Salvatorelli, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 17, 2012
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicinEmanuela Salvatorelli, Pierantonio Menna, Odalys Gonzalez Paz, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|February 17, 2012
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. I. Amrubicin accumulates to a lower level than doxorubicin or epirubicinEmanuela Salvatorelli, Pierantonio Menna, Sekhar Surapaneni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2012
Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosisEmanuela Salvatorelli, Michele De Tursi, Pierantonio Menna, et al.
Molecules (Basel, Switzerland)|February 24, 2024
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography-Tandem Mass SpectrometryLinda Molteni, Bruno Charlier, Albino Coglianese, et al.
Chemotherapy|November 21, 2018
Isavuconazole: Case Report and Pharmacokinetic ConsiderationsFrancesco Marchesi, Corrado Girmenia, Bianca Maria Goffredo, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2018
The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by AnthracyclinesPierantonio Menna, Emanuela Salvatorelli, Grazia Armento, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2019
Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b MinitrialGiorgio Minotti, Pierantonio Menna, Vito Calabrese, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2018
Pharmacology of Cardio-Oncology: Chronotropic and Lusitropic Effects of B-Type Natriuretic Peptide in Cancer Patients with Early Diastolic Dysfunction Induced by Anthracycline or Nonanthracycline ChemotherapyPierantonio Menna, Vito Calabrese, Grazia Armento, et al.
The Journal of Biological Chemistry|November 25, 2003
Oxidative degradation of cardiotoxic anticancer anthracyclines to phthalic acids. Novel function or ferrylmyoglobinAntonella Cartoni, Pierantonio Menna, Emanuela Salvatorelli, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 17, 2012
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicinEmanuela Salvatorelli, Pierantonio Menna, Odalys Gonzalez Paz, et al.
Pageof 7